Martin Shkreli

Entrepreneur and former hedge fund manager known for founding Turing Pharmaceuticals and igniting a national debate after raising the price of Daraprim more than 5,000%. His legal battles and defiant public persona made him a lightning rod for criticism. He has since shifted his focus to optical computing ventures.